Rimantas Zalepuga, MD
Gastroenterology · Bradenton, FLNPI 1316977499
Payments from drug & device makers
Across 364 payments — averaging $92.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Olympus America Inc.$25K
- AbbVie$4K
- QOL Medical, LLC$941
- Madrigal Pharmaceuticals$398
- Nestle Healthcare Nutrition Inc.$364
- Intra-sana Laboratories$296
- plus $2K from 27 others
What the payments were for
- Food & beverage$8,45625%
- Education$160%
- Other$25,21475%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Olympus America Inc. | 2 | $25,236 |
| AbbVie(2 entities) | 188 | $4,047 |
| QOL Medical, LLC | 29 | $941 |
| Madrigal Pharmaceuticals | 5 | $398 |
| Nestle Healthcare Nutrition Inc. | 24 | $364 |
| Intra-sana Laboratories | 5 | $296 |
| Aimmune Therapeutics, Inc. | 13 | $246 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $239 |
| Bristol Myers Squibb | 15 | $226 |
| Gilead | 7 | $222 |
| Johnson & Johnson | 8 | $195 |
| Pfizer | 9 | $187 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $159 |
| Intercept Pharmaceuticals, Inc. | 6 | $133 |
| Axonics, Inc. | 2 | $92 |
| Valencia Technologies Corporation | 1 | $78 |
| Ardelyx, Inc. | 4 | $77 |
| Ironwood Pharmaceuticals, Inc | 3 | $63 |
| Phathom Pharmaceuticals, Inc. | 3 | $60 |
| Braintree Laboratories, Inc. | 2 | $58 |
| Boston Scientific | 4 | $54 |
| Regeneron Healthcare Solutions, Inc. | 2 | $50 |
| Daiichi Sankyo Inc. | 2 | $32 |
| Novo Nordisk | 1 | $30 |
| Mauna Kea Technologies, Inc. | 1 | $28 |
| Medtronic | 1 | $28 |
| THD America, Inc. | 1 | $26 |
| Merck | 1 | $24 |
| Shionogi Inc | 1 | $23 |
| Lilly USA, LLC | 1 | $21 |
| Amgen | 1 | $20 |
| Alnylam Pharmaceuticals Inc. | 1 | $16 |
| Redhill Biopharma Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GASTROINTESTINAL VIDEOSCOPE$25,214
- Skyrizi$371
- REZDIFFRA$263
- Creon$133
- Livdelzi$125
- Reltone 200 Mg$124
- Reltone 400 Mg$124
How this compares
$33,686 in reported general payments places this provider in the 80th percentile of 1,388 gastroenterology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SucraidSacrosidase | 40 | $564,357 |
| CreonLipase/Protease/Amylase | 54 | $478,931 |
| ZenpepLipase/Protease/Amylase | 22 | $192,130 |
| Humira PenAdalimumab | 14 | $97,412 |
| LinzessLinaclotide | 42 | $50,911 |
| MovantikNaloxegol Oxalate | 28 | $23,167 |
| Ursodiol | 49 | $11,929 |
| Mesalamine | 16 | $5,404 |
| Budesonide DrBudesonide | 24 | $4,457 |
| Omeprazole | 218 | $4,078 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 48 | $3,079 |
| SutabSod Sulf/Pot Chloride/Mag Sulf | 16 | $2,617 |
| Pantoprazole Sodium | 148 | $2,468 |
| Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg | 60 | $1,293 |
| Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl | 50 | $891 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| QOL Medical, LLCSucraid | $941 | $564,35740 claims |
| AbbVieCreon, Linzess | $4,047 | $529,84296 claims |
| Aimmune Therapeutics, Inc.Zenpep | $246 | $192,13022 claims |
| Redhill Biopharma Inc.Movantik | $15 | $23,16728 claims |
| Braintree Laboratories, Inc.Sutab | $58 | $2,61716 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,388 gastroenterology providers in Florida.
Other gastroenterology in Bradenton
- Manuel RodriguezBradenton$1.7M
- Howard SchwartzTavernier$38.8M
- Guy NeffSarasota$17.6M
- Syed LateefClermont$6.4M
- Jeffrey SchneiderCoral Springs$6M
- Zaid RanaMiami$5.4M
- David NelsonGainesville$5.2M
- Alan WeintraubTampa$4.7M
- Curtis FreedlandNew Port Richey$4.5M
- Paul HellsternCrystal River$4.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.